These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10099426)

  • 1. Effects of methocel A15LV, polyethylene glycol, and polyvinyl alcohol on CD13 and CD33 receptor surface content and metabolism of HL60 cells cultured in stirred tank bioreactors.
    McDowell CL; Carver RT; Papoutsakis ET
    Biotechnol Bioeng; 1998 Oct; 60(2):251-8. PubMed ID: 10099426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum increases the CD13 receptor expression, reduces the transduction of fluid-mechanical forces, and alters the metabolism of HL60 cells cultured in agitated bioreactors.
    McDowell CL; Papoutsakis ET
    Biotechnol Bioeng; 1998 Oct; 60(2):259-68. PubMed ID: 10099427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors.
    McDowell CL; Papoutsakis ET
    Biotechnol Bioeng; 1998 Oct; 60(2):239-50. PubMed ID: 10099425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid-mechanical forces in agitated bioreactors reduce the CD13 and CD33 surface protein content of HL60 cells.
    Lakhotia S; Bauer KD; Papoutsakis ET
    Biotechnol Bioeng; 1993 Apr; 41(9):868-77. PubMed ID: 18609635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing extracellular pH increases CD13 receptor surface content and alters the metabolism of HL60 cells cultured in stirred tank bioreactors.
    McDowell CL; Papoutsakis ET
    Biotechnol Prog; 1998; 14(4):567-72. PubMed ID: 9694677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvinyl alcohol and polyethylene glycol as protectants against fluid-mechanical injury of freely-suspended animal cells (CRL 8018).
    Michaels JD; Papoutsakis ET
    J Biotechnol; 1991 Jul; 19(2-3):241-57. PubMed ID: 1367239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
    Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
    Dybkaer K; Olesen G; Pedersen FS; Kristensen JS
    Eur J Haematol; 2001 Mar; 66(3):168-77. PubMed ID: 11350485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: shear, proliferation, and the IL-2 receptor.
    Carswell KS; Papoutsakis ET
    Biotechnol Bioeng; 2000 May; 68(3):328-38. PubMed ID: 10745201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cell-to-bubble attachment in sparged bioreactors in the presence of cell-protecting additives.
    Michaels JD; Nowak JE; Mallik AK; Koczo K; Wasan DT; Papoutsakis ET
    Biotechnol Bioeng; 1995 Aug; 47(4):407-19. PubMed ID: 18623417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
    Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
    Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
    Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.
    Kawada H; Ichikawa Y; Kobayashi N; Fukuda R; Yonekura S; Nagao T
    Intern Med; 1993 Sep; 32(9):733-6. PubMed ID: 7908235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
    Larson RS; McCurley TL
    Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoterpenoid oxindole alkaloid production by Uncaria tomentosa (Willd) D.C. cell suspension cultures in a stirred tank bioreactor.
    Trejo-Tapia G; Cerda-García-Rojas CM; Rodríguez-Monroy M; Ramos-Valdivia AC
    Biotechnol Prog; 2005; 21(3):786-92. PubMed ID: 15932257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of thyroid-stimulating antibody-stimulated cyclic adenosine monophosphate response by polyethylene glycol, polyvinyl alcohol, and dextran; highly sensitive porcine thyroid cell thyroid-stimulating antibody assay.
    Yamashiro K; Takasu N; Kouki T; Inui T; Ochi Y; Kajita Y; Sato Y; Nagata A
    Thyroid; 1999 Mar; 9(3):263-71. PubMed ID: 10211603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing bioreactor hiPSC aggregate stability, maintenance and scaleup challenges using a design of experiment approach.
    Yehya H; Raudins S; Padmanabhan R; Jensen J; Bukys MA
    Stem Cell Res Ther; 2024 Jul; 15(1):191. PubMed ID: 38956608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.